NCT03763149 · Interventional trial
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas
Overall registry status Completed
Phase 1
Conditions Advanced Malignancies
Delaware Valley sites
- Thomas Jefferson Univerity · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory